Resources

1 Resources for

merck

  • Subscribe to this listing via:
  • RSS
  • Email
Did you mean Merck & Co. Inc. (2,156 results), Merck Serono International Sa

Additional Resources

Merck and Schering-Plough Receive Request for Additional Information from FTC Regarding Proposed Merger
WHITEHOUSE STATION, N.J. & KENILWORTH, N.J. -- Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) today announced that they each have received a request for ...
Articles 2009-06-22
InvestorSoup.com Researches Finish Line, Merck, Marvell, VeriSign, Apple, CBS
DALLAS, June 22 /PRNewswire/ -- InvestorSoup.com announces the availability of stock alerts on leading, active solar stocks making news in this week's trading session. Each stock alert includes recent news, trading activity, technical analysis and relevant market research you need to know. Investors can view all of...
Articles 2009-06-22
Merck Prices $4.25 Billion Debt Offering
WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. priced today a $4.25 billion public offering of senior unsecured notes. The notes include: ...
Articles 2009-06-22
Holes in case against Vioxx: Merck.
Byline: Milanda Rout Jun 22, 2009 (The Australian - ABIX via COMTEX) -- The defence has made its closing arguments in the class action case brought by sufferers from alleged side-effects of the Vioxx anti-arthritis drug against manufacturer Merck. The Federal Court of...
Articles 2009-06-22
Drug's heart attack risk findings 'flawed'.
Byline: Kate Hagan Jun 22, 2009 (The Age - ABIX via COMTEX) -- Pharmaceutical company, Merck, has argued that conclusions about the risk of anti-arthritis drug Vioxx were flawed. Cardiologists told the Federal Court that the risk of the lead claimant having a...
Articles 2009-06-22
Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer
SEATTLE, June 22 /PRNewswire-FirstCall/ -- Oncothyreon Inc. (TSX:ONY) (the "Company") today announced that Merck KGaA of Darmstadt, Germany, has initiated a global Phase 3 trial of StimuvaxR (BLP25 liposome vaccine, L-BLP25) in patients with hormone receptor-positive, locally advanced, recurrent or metastatic breast cancer. Stimuvax is an investigational therapeutic...
Articles 2009-06-22
Merck & Co., Inc. and Drugs for Neglected Diseases initiative Collaborate to Find Treatments for World's Most Neglected Tropical Diseases
NAIROBI, Kenya & WHITEHOUSE STATION, N.J. -- On the eve of an international meeting bringing together 200 African researchers to discuss progress on research for neglected tropical diseases...
Articles 2009-06-22
Fitch Rates Merck & Co.'s Debt Offering 'AA-'
CHICAGO -- Fitch Ratings has assigned an 'AA-' rating to Merck & Co.'s Merck proposed public issuance of $3.5 billion in senior unsecured notes comprising four tranches. The...
Articles 2009-06-22
Merck & Co., Inc. Statement on Medicare Part D Assistance
WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. today said it supports a proposal to provide additional assistance to Medicare Part D beneficiaries who have reached the coverage...
Articles 2009-06-20
PennyStockOfficial.com Issues Technical Trade Alerts on Market Movers Today: C, PFE, F, CSCO, USB, MRK
ROCHESTER, N.Y., June 19 /PRNewswire/ -- PennyStockOfficial.com is pleased to offer its stock alerts service to the investing community. Investors who are interested in stocks on the move and in the news can receive FREE Alerts by visiting the following link: PennyStockOfficial.com Today's focused alerts include: Citigroup,...
Articles 2009-06-19
Zacks Analyst Blog Highlights: PG&E, Con Ed, Schering-Plough, Merck & Co., Inc. and Johnson & Johnson.
http://www.profit.zacks.com/ CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity...
Articles 2009-06-19
Technical Trade Alerts For Healthcare Stocks: Issued By BestDamnPennyStocks.com
ROCHESTER, N.Y., June 18 /PRNewswire/ -- BestDamnPennyStocks.com is pleased to offer its stock alerts service to the investing community. Investors who are interested in stocks on the move and in the news can receive FREE Alerts by visiting the following link: http://www.bestdamnpennystocks.com/ Investors can view all of...
Articles 2009-06-18
Publisher consulted drug firm on journal content.
Byline: Milanda Rout Jun 18, 2009 (The Australian - ABIX via COMTEX) -- In the class action case brought by sufferers from alleged side-effects of the Vioxx anti-arthritis drug against manufacturer Merck, the Federal Court of Australia has heard that international medical publisher...
Articles 2009-06-18
VIVALIS AND MERIAL ANNOUNCE THE SIGNING OF A NEW RESEARCH LICENSE FOR 10 VACCINES
VIVALIS AND MERIAL EXTENDTHEIR COLLABORATION BY SIGNING A NEW EB66® CELL LINE RESEARCH LICENSEAGREEMENT FOR 10 NEW VACCINES PRODUCTION. Nantes France & Duluth, GA USA - June 16th , 2009- VIVALIS (NYSEEuronext: VLS) and MERIAL a joint venture between sanofi aventis andMerck, today announced the signing of a new research...
Articles 2009-06-16
Zacks Analyst Blog Highlights: Community Health Systems Inc., Universal Health Services Inc., Merck & Co., Inc., Schering-Plough and Johnson & Johnson
http://www.profit.zacks.com/ CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity...
Articles 2009-06-16
Adimab Launches Novel Antibody Discovery Platform and Announces Discovery Programs with Merck and Roche
LEBANON, N.H. -- Adimab, Inc., an emerging leader in the discovery of fully human antibodies, today announced the launch of a unique human antibody discovery platform based on...
Articles 2009-06-16
AnalystChoice.com Brings You the Best Complimentary Research Report on MRK, AMX, STLD and BRCD
Analyst Choice has combined some of thebest financial and technical minds worldwide to bring you an array of freequality equity research and reporting. Today we have begun in-depthreporting on our website evaluating the current market condition of Merck &Co. Inc. (NYSE: MRK), America Movil S.A.B. de C.V. (NYSE: AMX),...
Articles 2009-06-16
Koch hosted Vioxx video for GPs.
Byline: Milanda Rout Jun 16, 2009 (The Australian - ABIX via COMTEX) -- In the class action case brought by sufferers from alleged side-effects of the Vioxx anti-arthritis drug against manufacturer Merck, the Federal Court of Australia has heard of a training CD...
Articles 2009-06-16
Stock Alerts on Monday's Market Movers; Issued by InvestorSoup.com
DALLAS, June 15 /PRNewswire/ -- InvestorSoup.com announces the availability of stock alerts on leading, active stocks in today's news. Each stock alert highlights recent news, trading activity, technical analysis and relevant market research you need to know. Investors can view all of the daily stock alerts for...
Articles 2009-06-15
  • << Previous
  • page 1 of 1
  • Next >>
advertisement
advertisement